- Home
- AUPH vs GABC Comparison
AUPH vs GABC Comparison
Compare AUPH & GABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- GABC
- Stock Information
- Founded
- AUPH 1993
- GABC 1910
- Country
- AUPH Canada
- GABC United States
- Employees
- AUPH N/A
- GABC 1020
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- GABC Major Banks
- Sector
- AUPH Health Care
- GABC Finance
- Exchange
- AUPH Nasdaq
- GABC Nasdaq
- Market Cap
- AUPH 1.1B
- GABC 1.4B
- IPO Year
- AUPH 1999
- GABC N/A
- Fundamental
- Price
- AUPH $8.13
- GABC $37.88
- Analyst Decision
- AUPH Strong Buy
- GABC Buy
- Analyst Count
- AUPH 2
- GABC 4
- Target Price
- AUPH $11.50
- GABC $46.00
- AVG Volume (30 Days)
- AUPH 1.7M
- GABC 116.0K
- Earning Date
- AUPH 05-01-2025
- GABC 04-28-2025
- Dividend Yield
- AUPH N/A
- GABC 3.08%
- EPS Growth
- AUPH N/A
- GABC N/A
- EPS
- AUPH 0.04
- GABC 2.83
- Revenue
- AUPH $235,133,000.00
- GABC $250,476,000.00
- Revenue This Year
- AUPH $13.80
- GABC $43.16
- Revenue Next Year
- AUPH $24.57
- GABC $7.60
- P/E Ratio
- AUPH $203.13
- GABC $13.35
- Revenue Growth
- AUPH 33.97
- GABC 0.94
- 52 Week Low
- AUPH $4.71
- GABC $31.06
- 52 Week High
- AUPH $10.67
- GABC $47.08
- Technical
- Relative Strength Index (RSI)
- AUPH 51.32
- GABC 38.77
- Support Level
- AUPH $7.92
- GABC $37.51
- Resistance Level
- AUPH $8.85
- GABC $39.07
- Average True Range (ATR)
- AUPH 0.42
- GABC 0.78
- MACD
- AUPH 0.04
- GABC -0.14
- Stochastic Oscillator
- AUPH 69.72
- GABC 28.01
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About GABC German American Bancorp Inc.
German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.